<DOC>
	<DOCNO>NCT01208961</DOCNO>
	<brief_summary>The objective study compare relative bioavailabilities eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) plasma single dose Epanova Lovaza period high- low -fat consumption .</brief_summary>
	<brief_title>Epanova® Compared Lovaza® In Pharmacokinetic , Single-dose , Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<criteria>Men woman , age ≥18 . Normal healthy volunteer base medical history , clinical assessment , laboratory assessment . Body mass index 2535 kg/m2 . Willingness maintain current activity level . Willingness adhere Therapeutic Lifestyle Changes ( TLC ) diet screen treatment washout period . Intolerance omega3 fatty acid , ethyl ester , fish . Unable unwilling eat study meal . Use fish oil , EPA DHA contain supplement , EPA and/or DHA fortify food within 60 day Visit 2 , study . Consumption fish within 7 day Visit 2 , study . Use flaxseed , perilla seed , hemp , spirulina , black currant oil within 7 day Visit 2 , study . History malabsorption syndrome , Crohn 's disease , acute chronic pancreatitis , pancreatic insufficiency , small bowel resection . Women pregnant , lactating , plan become pregnant study period , woman childbearing potential use acceptable contraceptive method . A woman consider childbearing potential surgically sterile less 1 year since last menstrual period . Examples acceptable contraceptive method include abstinence , intrauterine device ( IUD ) double barrier method , oral injectable contraceptive . Recent history ( past 12 month ) drug abuse alcohol abuse . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz beer , 5 oz wine , 1.5 oz hard liquor ) . Exposure investigational product , within 28 day prior Visit 1 . Any condition investigator believe would interfere subject 's ability provide inform consent , comply study instruction , might confound interpretation study result put subject undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Eicosapentaenoic Acid</keyword>
	<keyword>Docosahexaenoic Acid</keyword>
	<keyword>Hypertriglyceridemia</keyword>
	<keyword>Omega-3 acid ethyl ester</keyword>
	<keyword>Omega-3 carboxylic acid</keyword>
	<keyword>Epanova</keyword>
	<keyword>Lovaza</keyword>
	<keyword>bioavailability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>low-fat meal</keyword>
	<keyword>high-fat meal</keyword>
</DOC>